EU investments in heart research goes to animal experiments with no view to alternatives

#Act4
LabAnimals

EU investments in heart research goes to animal experiments with no view to alternatives

14 January 2019
News
Professor Dr Mariann Gyöngyösi from the Experimental and Clinical Invasive Cardiology Laboratory of the Medical University of Vienna discusses different animal models in the context of her group’s research into treatments for cardiovascular diseases.

Large animals still remain the best tool to investigate severe diseases, such as cardiovascular diseases,’ Biondi-Zoccai G. 2013. One of the continuing aims of the pharmaceutical and medical device industries is the development of new and better pharmaceuticals and devices to help cure illnesses. Before applications of new medicines and medical devices reach humans, rigorous in vitro and in vivo experiments are performed to prove the safety of the new treatment mode. For in vivo testing, small (e.g. rodents) and large animals (e.g. pigs) are used, depending on the scientific and medical questions being asked, considering the ‘3R rules’ (replace, reduce, refine) of animal experiments, and the veterinary ethical issues.